Over
Professor Mark Beresford is a Consultant Clinical Oncologist working at the Royal United Hospital Bath, specialising in breast and urological malignancies.
Professor Beresford undertook his initial medical training at Gonville and Caius College, Cambridge University (1989-1992) before moving on to Oxford University for clinical training (1992-1995). Mark then moved to London for his junior doctor and specialist oncology training at St Mary's, University College, Charing Cross and Mount Vernon Hospitals. His passion for medical research led him to receive a Doctorate of Medicine from Oxford University for research into predicting response to chemotherapy in breast cancer and was awarded the Frank Doyle Medal for the highest mark in the Royal College of Radiologists oncology fellowship exams; a trajectory of excellence he has continued on throughout his career.
Mark was appointed as a consultant in oncology at University Hospital Bristol in 2006, moving his NHS practice to Royal United Hospital Bath in 2011. He is active in clinical research at a national level, being principal investigator on many trials and an active member of the National Cancer Research Institute Breast Cancer Clinical Studies Group since 2010. He is an Honorary Senior Lecturer at Bristol University and Visiting Researcher at Bath University and has been awarded grants for local clinical trials. He is particularly interested in methods for early assessment of benefit from treatment.
Mark has advised NICE on the adoption and appraisal of new chemotherapy drugs, is a committee member of the British Uro-oncology Group and the Penny Brohn complimentary therapy centre. He is also a member of Innovators in Breast Cancer and Action for Bladder Cancer groups. He has personally authored over 50 scientific journal articles, conference posters and textbook chapters. Professor Beresford is renowned in his field and there are few better qualified clinicians to see patients in private practice.
Diseases, Medical Tests and TreatmentsChemotherapy
Radiotherapy
Breast cancer
Kidney (renal) cancer
Prostate disease including prostate cancer
Urological oncology
Bladder cancer
Brain tumours
Professor Beresford undertook his initial medical training at Gonville and Caius College, Cambridge University (1989-1992) before moving on to Oxford University for clinical training (1992-1995). Mark then moved to London for his junior doctor and specialist oncology training at St Mary's, University College, Charing Cross and Mount Vernon Hospitals. His passion for medical research led him to receive a Doctorate of Medicine from Oxford University for research into predicting response to chemotherapy in breast cancer and was awarded the Frank Doyle Medal for the highest mark in the Royal College of Radiologists oncology fellowship exams; a trajectory of excellence he has continued on throughout his career.
Mark was appointed as a consultant in oncology at University Hospital Bristol in 2006, moving his NHS practice to Royal United Hospital Bath in 2011. He is active in clinical research at a national level, being principal investigator on many trials and an active member of the National Cancer Research Institute Breast Cancer Clinical Studies Group since 2010. He is an Honorary Senior Lecturer at Bristol University and Visiting Researcher at Bath University and has been awarded grants for local clinical trials. He is particularly interested in methods for early assessment of benefit from treatment.
Mark has advised NICE on the adoption and appraisal of new chemotherapy drugs, is a committee member of the British Uro-oncology Group and the Penny Brohn complimentary therapy centre. He is also a member of Innovators in Breast Cancer and Action for Bladder Cancer groups. He has personally authored over 50 scientific journal articles, conference posters and textbook chapters. Professor Beresford is renowned in his field and there are few better qualified clinicians to see patients in private practice.
Diseases, Medical Tests and TreatmentsChemotherapy
Radiotherapy
Breast cancer
Kidney (renal) cancer
Prostate disease including prostate cancer
Urological oncology
Bladder cancer
Brain tumours
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Professor Mark Beresford
Opleiding & training
-
2002–2008 MD · Medicine and Surgery
-
2008–2012 Residency · Oncologie
-
2012–2013 Fellowship · Subspecialty training
Carrière & aanstellingen
-
2012-09–2013-08 Junior consultant
Vergunningen & verzekering
Medische licenties
GB — Organización Médica Colegial de España (OMC)
Boardcertificeringen
European Board of Oncologie
Beroepsaansprakelijkheidsverzekering:
AmTrust Europe · 5,000,000 EUR dekking · No claims on file
Uitgevoerde procedures
| Procedure | Code | Levenslang aantal |
|---|---|---|
| GP consultation | 99213 | 393 |
| Annual physical exam | 99395 | 2,415 |
| Vaccination administration | 90471 | 2,423 |
| Minor procedure (skin) | 17110 | 656 |
Diensten & prijzen
| Dienst | Duur | Modaliteit | Prijs |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 270.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 360.00 EUR |
Praktijk, team & in praktijk
Video's
Onderzoek & publicaties
h-index: 12 · i10: 10
-
Outcomes of Oncologie in adults — a multi-centre cohort
DOI: 10.5246/euroclin.2025.0 · PMID: 33245157 · geciteerd door 9
-
European registry analysis of Oncologie outcomes
DOI: 10.8120/euroclin.2024.1 · PMID: 38168448 · geciteerd door 11
-
Outcomes of Oncologie in adults — a multi-centre cohort
DOI: 10.1819/euroclin.2023.2 · PMID: 30684374 · geciteerd door 13
Uitgenodigde lezingen
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · Swindon · 2023 · oral abstract
Onderscheidingen & lidmaatschappen
Onderscheidingen
- 🏆 Top-rated Oncologie — Swindon · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Lidmaatschappen
- WONCA Europe — Family Doctors — Member · Sinds 2013
- national college of family doctors — Member · Sinds 2013
- European Union of Medical Specialists (UEMS) — Member · Sinds 2013
Artikelen van deze arts
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Voor internationale patiënten
- Coördinator
- Patient liaison · professor.mark.beresford@euroclinics.example
- Geaccepteerde internationale verzekeringen
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Locatie
1 tagPatiëntbeoordelingen
6 geverifieerde recensies5.00
★★★★★
6 recensies
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Deel uw ervaring — help andere patiënten de juiste arts te vinden. Schrijf een recensie →
Recente recensies
-
★★★★★ ✓ Geverifieerd Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Geverifieerd Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Geverifieerd Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Vergelijkbare specialisten
Alles bladeren →
Mr Abdulla Alhasso
Oncologie · Glasgow
Dr Alexander McDonald
Oncologie · Glasgow
Dr Amna Sheri
Oncologie · London
Dr Angus Robinson
Oncologie · Horley
Dr Anne Armstrong
Oncologie · Manchester
Dr Ashraf Azzabi
Oncologie · Washington
Dr Clare Green
Oncologie · Winchester
Dr Desmond Yip
Oncologie · Garran